Why enroll in My VYVGART Path?

My VYVGART Path is a patient support program that pairs you with a dedicated Nurse Case Manager (NCM), who can help you navigate insurance, offer resources, talk through your challenges, and more.

NCM=Nurse Case Manager

Information provided by the Nurse Case Managers is not intended or implied to be a substitute for professional medical advice, diagnosis, or treatment. Always consult with a qualified and licensed physician or other healthcare provider regarding your medical condition, treatment, and healthcare needs.

 

My VYVGART Path may help improve access to treatment for people with anti-AChR antibody positive gMG

AChR=acetylcholine receptor; gMG=generalized myasthenia gravis

What to expect throughout your treatment journey

See how My VYVGART Path is here to guide you throughout each step of the journey listed below.

My VYVGART Path enrollment, cost and coverage information, treatment begins, and symptom tracking and treatment planning. My VYVGART Path enrollment, cost and coverage information, treatment begins, and symptom tracking and treatment planning. My VYVGART Path enrollment, cost and coverage information, treatment begins, and symptom tracking and treatment planning.

There are 2 options to enroll once your doctor has prescribed you VYVGART:

Option 1

Speak with your doctor and ask to be enrolled in My VYVGART Path.

Option 2

Download the enrollment form.

PATIENT ENROLLMENT FORM

 

Once enrolled in My VYVGART Path, you will receive a call from an NCM to welcome you into the program. A welcome kit will be mailed to you that includes a symptom tracking journal and other helpful resources.

An NCM works with your support team to help you and your doctor’s office navigate the insurance process and understand your plan’s coverage requirements for VYVGART Hytrulo or VYVGART.

The My VYVGART Path team will complete a benefits investigation to help provide you with personalized information about your insurance coverage, potential financial assistance programs, and possible out-of-pocket costs.

As you begin treatment, an NCM is here to answer questions you and your loved ones may have. They can help with things like:

  • Explaining how VYVGART Hytrulo and VYVGART for intravenous (IV) infusion work
  • Helping you understand dosing and personalized breaks between cycles
  • Providing resources to set treatment goals to share with your doctor
  • Sharing educational information and resources on the injection or infusion process

IV=intravenous

LEARN MORE
6.1-NCM full illlustration-D

An NCM can teach you about tracking your symptoms with a symptom tracker, which helps determine your treatment plan.

Track your symptoms in a way that fits you

Download the
Medisafe app*

Download the
MG-ADL assessment tool

Write them in your symptom tracking journal found in the welcome kit

*Reach out to your NCM for an access code that unlocks app features.

MG-ADL=Myasthenia Gravis Activities of Daily Living

Survey results showing that approximately 9 out of 10 people with anti-AChR antibody positive generalized myasthenia gravis were satisfied with the support received through My VYVGART Path

people with anti-AChR antibody positive gMG were satisfied with the support received through My VYVGART Path*

*Based on an online survey from October 2023 of 79 respondents enrolled in My VYVGART Path.

My VYVGART Path

Enroll in My VYVGART Path

There are 2 options to enroll once your doctor has prescribed you VYVGART:

Option 1

Speak with your doctor and ask to be enrolled in My VYVGART Path.

Option 2

Download the enrollment form.

PATIENT ENROLLMENT FORM

Once enrolled in My VYVGART Path, you will receive a call from an NCM to welcome you into the program. A welcome kit will be mailed to you that includes a symptom tracking journal and other helpful resources.

Image of Fred a person living with gMG
Image of Fred a person living with gMG
If you’re on VYVGART, I would recommend you use My VYVGART Path. There’s a lot of support out there that you don’t know exists.

Fred

VYVGART patient
Fred is a paid spokesperson of argenx.

Resources to get you started

What’s Next guide

The “What’s Next?” patient guide outlines what you can expect as you begin your treatment journey.

Download now

My VYVGART Path brochure

See how the My VYVGART Path Patient Support Program can empower you on your treatment journey.

Download now

Co-pay Program brochure

If you have commercial or private insurance, you may be eligible for assistance through the VYVGART Co-pay Program.

Download now

Image of person tracking symptoms using an app on their phone

Tools for your journey

Did you know there's an app you can download with a lot of helpful tools such as tracking symptoms and communicating with your NCM?

EXPLORE RESOURCES

Get the latest VYVGART updates

Sign up to get the latest information about VYVGART sent straight to your inbox.

SIGN UP NOW
Footer logos
VYVGART®-Combined-RGB_KO-VERTICAL

Still have questions? Call 1-833-VYVGART (1-833-898-4278) to speak with an educator about gMG, how VYVGART works, study data, cost and coverage, and more.

Do not use VYVGART if you have a serious allergy to efgartigimod alfa or any of the other ingredients in VYVGART. Do not use VYVGART HYTRULO if you have a serious allergy to efgartigimod alfa, hyaluronidase, or any of the other ingredients in VYVGART HYTRULO. VYVGART and VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

VYVGART and VYVGART HYTRULO may cause serious side effects, including:

  • Infection. VYVGART and VYVGART HYTRULO may increase the risk of infection. The most common infections for efgartigimod alfa-fcab-treated patients were urinary tract and respiratory tract infections. Signs or symptoms of an infection may include fever, chills, frequent and/or painful urination, cough, pain and blockage of nasal passages/sinus, wheezing, shortness of breath, fatigue, sore throat, excess phlegm, nasal discharge, back pain, and/or chest pain.
  • Allergic Reactions (hypersensitivity reactions). VYVGART and VYVGART HYTRULO can cause allergic reactions such as rashes, swelling under the skin, and shortness of breath. Hives were also observed in patients treated with VYVGART HYTRULO. Serious allergic reactions, such as trouble breathing and decrease in blood pressure leading to fainting have been reported with efgartigimod alfa-fcab.
  • Infusion-Related Reactions. VYVGART and VYVGART HYTRULO can cause infusion-related reactions. The most frequent symptoms and signs reported with efgartigimod alfa-fcab were high blood pressure, chills, shivering, and chest, abdominal, and back pain.

Tell your doctor if you have signs or symptoms of an infection, allergic reaction, or infusion-related reaction. These can happen while you are receiving your VYVGART or VYVGART HYTRULO treatment or afterward. Your doctor may need to pause or stop your treatment. Contact your doctor immediately if you have signs or symptoms of a serious allergic reaction.

Before taking VYVGART or VYVGART HYTRULO, tell your doctor if you:

  • take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines,
  • have received or are scheduled to receive a vaccine (immunization), or
  • have any allergies or medical conditions, including if you are pregnant or planning to become pregnant, or are breastfeeding.

What are the common side effects of VYVGART and VYVGART HYTRULO?

The most common side effects in efgartigimod-alfa-fcab-treated patients were respiratory tract infection, headache, and urinary tract infection. Additional common side effects with VYVGART HYTRULO are injection site reactions, including rash, redness of the skin, itching sensation, bruising, pain, and hives.

These are not all the possible side effects of VYVGART and VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.

What is VYVGART® (efgartigimod alfa-fcab) for intravenous (IV) infusion and what is VYVGART® HYTRULO (efgartigimod alfa and hyaluronidase-qvfc) for subcutaneous injection?

VYVGART and VYVGART HYTRULO are both prescription medicines, each used to treat a condition called generalized myasthenia gravis, which causes muscles to tire and weaken easily throughout the body, in adults who are positive for antibodies directed toward a protein called acetylcholine receptor (anti-AChR antibody positive).

Please see the full Prescribing Information for VYVGART and the full Prescribing Information for VYVGART HYTRULO, and talk to your doctor.

Do not use VYVGART if you have a serious allergy to efgartigimod alfa or any of the other ingredients in VYVGART. Do not use VYVGART HYTRULO if you have a serious allergy to efgartigimod alfa, hyaluronidase, or any of the other ingredients in VYVGART HYTRULO. VYVGART and VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

VYVGART and VYVGART HYTRULO may cause serious side effects, including:

  • Infection. VYVGART and VYVGART HYTRULO may increase the risk of infection. The most common infections for efgartigimod alfa-fcab-treated patients were urinary tract and respiratory tract infections. Signs or symptoms of an infection may include fever, chills, frequent and/or painful urination, cough, pain and blockage of nasal passages/sinus, wheezing, shortness of breath, fatigue, sore throat, excess phlegm, nasal discharge, back pain, and/or chest pain.
  • Allergic Reactions (hypersensitivity reactions). VYVGART and VYVGART HYTRULO can cause allergic reactions such as rashes, swelling under the skin, and shortness of breath. Hives were also observed in patients treated with VYVGART HYTRULO. Serious allergic reactions, such as trouble breathing and decrease in blood pressure leading to fainting have been reported with efgartigimod alfa-fcab.
  • Infusion-Related Reactions. VYVGART and VYVGART HYTRULO can cause infusion-related reactions. The most frequent symptoms and signs reported with efgartigimod alfa-fcab were high blood pressure, chills, shivering, and chest, abdominal, and back pain.

Tell your doctor if you have signs or symptoms of an infection, allergic reaction, or infusion-related reaction. These can happen while you are receiving your VYVGART or VYVGART HYTRULO treatment or afterward. Your doctor may need to pause or stop your treatment. Contact your doctor immediately if you have signs or symptoms of a serious allergic reaction.

Before taking VYVGART or VYVGART HYTRULO, tell your doctor if you:

  • take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines,
  • have received or are scheduled to receive a vaccine (immunization), or
  • have any allergies or medical conditions, including if you are pregnant or planning to become pregnant, or are breastfeeding.

What are the common side effects of VYVGART and VYVGART HYTRULO?

The most common side effects in efgartigimod-alfa-fcab-treated patients were respiratory tract infection, headache, and urinary tract infection. Additional common side effects with VYVGART HYTRULO are injection site reactions, including rash, redness of the skin, itching sensation, bruising, pain, and hives.

These are not all the possible side effects of VYVGART and VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.

What is VYVGART® (efgartigimod alfa-fcab) for intravenous (IV) infusion and what is VYVGART® HYTRULO (efgartigimod alfa and hyaluronidase-qvfc) for subcutaneous injection?

VYVGART and VYVGART HYTRULO are both prescription medicines, each used to treat a condition called generalized myasthenia gravis, which causes muscles to tire and weaken easily throughout the body, in adults who are positive for antibodies directed toward a protein called acetylcholine receptor (anti-AChR antibody positive).

Please see the full Prescribing Information for VYVGART and the full Prescribing Information for VYVGART HYTRULO, and talk to your doctor.

Questions? Call 1-833-VYVGART
(1-833-898-4278)

This site is intended for patients and caregivers.

Disclaimer | Privacy Policy | Contact Us |

Prescribing Information
VYVGART for IV infusion Prescribing Information VYVGART Hytrulo for subcutaneous injection Prescribing Information

VYVGART is a registered trademark of argenx.
VYVGART Hytrulo is a trademark of argenx.

For U.S. audiences only.

©2024 argenx 

US-VYV-23-00232 V5 07/2024

argenx